Near the end of June 2023, Luxembourg joined other countries in legalizing adult-use cannabis.
Luxembourg became the second European Union member nation to legalize adult-use cannabis (1). Through their new reform laws, cannabis possession and personal use cultivation are legalized. With this new legislation, adults can now grow up to 4 plants and possess up to 3 grams. Public use is still banned, and individuals could be fine anywhere between $27 - $500. The law passed 38-22 (2).
Minister of Justice Sam Tanson mentioned that, “The cultivation, from seeds, of four cannabis plants per domestic community is authorized for adults. As a corollary, personal consumption in the private sphere is authorized. The place of cultivation must be either the domicile or the habitual residence and the plants must not be visible from the public road. At the same time, a simplified criminal procedure is introduced for certain behaviors which remain prohibited, namely the consumption, possession, transport and acquisition in public, for their sole personal use, of a maximum of three grams of cannabis by adult persons,” (3)
In October 2021, cannabis cultivation was legalized for adults, but lawmakers had not codified the rules or agreed on personal possession limits. This led to a delay in implementing the reforms. In order to take effect, the new law must be published in the Official Gazette.
Luxembourg legalized medical cannabis in 2018. It also decriminalized cannabis in 2001.
In 2021, Malta became the first European Union country (1) to legalize cannabis for recreational use. They also created a legal framework for cannabis social clubs. Officials have still not issued any cannabis club licenses. In regard to Luxembourg, they have not formed any channels for legal sales or social use yet.
Luxembourg’s Josée Lorsché, a Green Party member of the Judiciary Committee, hinted that the country’s next move will be to establish regulated systems for cannabis production and for sales to be managed by the government.
According to the Ministry of Justice’s recent statement (4):
“On July 17, 2023, the law of July 10, 2023, amending the amended law of February 19, 1973, concerning the sale of medicinal substances and the fight against drug addiction, providing for the legalization of the domestic cultivation of cannabis under certain conditions, has been published in the Official Journal. It will enter into force on the fourth day following the day of its publication, i.e. Friday, July 21, 2023.”
References
A Consumer Trends Survey of Minor Cannabinoids
March 6th 2025This survey assesses consumer awareness, usage patterns, and safety concerns with results indicating that cannabidiol (CBD), Δ8-tetrahydrocannabinol (Δ8-THC), and cannabinol (CBN) are the most frequently used cannabinoids, with vapes and edibles being the preferred methods of consumption.
Ep 25: Cannabis Quality Differentiation Beyond Cannabinoid Content
February 28th 2025In this latest installment of Noid Knowledge we are joined by Julie Kowalski, a leading mind in analytical chemistry and cannabis testing. Julie has arranged a very compelling symposium for Pittcon entitled Cannabis Aroma: Advances and Challenges in Determining and Commercializing Cannabis Product Quality Attributes. It is taking place on Wednesday, March 5, 2025, starting at 9:30 AM in room 209. The session features top notch speakers, including several previous guests of this show, and yours truly, discussing the next generation of quality assessment in cannabis.
A Call for More Representative Horticultural Lighting Metrics for Cannabis Cultivation
March 5th 2025This article explores fundamental principles of photobiology, including Photosynthetically Active Radiation, photoreceptor-mediated responses, and the spectral influences on plant morphology and development.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.